313 related articles for article (PubMed ID: 34771430)
1. Adrenocortical Carcinoma in Childhood: A Systematic Review.
Riedmeier M; Decarolis B; Haubitz I; Müller S; Uttinger K; Börner K; Reibetanz J; Wiegering A; Härtel C; Schlegel PG; Fassnacht M; Wiegering V
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771430
[TBL] [Abstract][Full Text] [Related]
2. Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.
Evanoff JD; Patel SG; Hickey KJ; Rensing AJ
J Pediatr Urol; 2021 Oct; 17(5):735.e1-735.e6. PubMed ID: 34210620
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
4. Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.
Ettaieb M; Kerkhofs T; van Engeland M; Haak H
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414074
[TBL] [Abstract][Full Text] [Related]
5. 12-Year-Old Girl Diagnosed With Li-Fraumeni Syndrome and Concomitant Adrenocortical Carcinoma (ACC).
Donato UM; Torres D; Galligan A
Cureus; 2022 Oct; 14(10):e30836. PubMed ID: 36457625
[TBL] [Abstract][Full Text] [Related]
6. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Insights into DNA Mismatch Repair (MMR) Genes-Proteins and Microsatellite Instability: Focus on Adrenocortical Carcinoma and Beyond.
Carsote M; Turturea IF; Turturea MR; Valea A; Nistor C; Gheorghisan-Galateanu AA
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296718
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Clinical review: Adrenocortical carcinoma: clinical update.
Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2027-37. PubMed ID: 16551738
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors in high-risk childhood adrenocortical carcinomas: A report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).
Cecchetto G; Ganarin A; Bien E; Vorwerk P; Bisogno G; Godzinski J; Dall'Igna P; Reguerre Y; Schneider D; Brugières L; Leblond P; Ferrari A; Brecht I; De Paoli A; Orbach D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27957799
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following surgical management of adrenocortical carcinoma: A single-center experience.
Turco M; Huguet J; Territo A; Fontana M; Rodriguez Faba O; Palou J; Breda A
Arch Esp Urol; 2021 Oct; 74(8):782-789. PubMed ID: 34605409
[TBL] [Abstract][Full Text] [Related]
12. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
[TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
14. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017.
Gupta N; Rivera M; Novotny P; Rodriguez V; Bancos I; Lteif A
Horm Res Paediatr; 2018; 90(1):8-18. PubMed ID: 29804118
[TBL] [Abstract][Full Text] [Related]
17. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
18. DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry.
Clay MR; Pinto EM; Cline C; Tran QT; Lin T; Dyer MA; Shi L; Wu H; Pounds SB; Zambetti GP; Orr BA; Ribeiro RC
JCO Precis Oncol; 2019; 3():. PubMed ID: 32923859
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Children With Adrenocortical Carcinoma in the Context of Germline TP53 Status.
Brenna CTA; Michaeli O; Wasserman JD; Malkin D
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e635-e641. PubMed ID: 33122580
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
